Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 18;10(10):1740.
doi: 10.3390/vaccines10101740.

Epigenetics in Tuberculosis: Immunomodulation of Host Immune Response

Affiliations
Review

Epigenetics in Tuberculosis: Immunomodulation of Host Immune Response

Avinash Khadela et al. Vaccines (Basel). .

Abstract

Tuberculosis is a stern, difficult to treat chronic infection caused by acid-fast bacilli that tend to take a long time to be eradicated from the host's environment. It requires the action of both innate and adaptive immune systems by the host. There are various pattern recognition receptors present on immune cells, which recognize foreign pathogens or its product and trigger the immune response. The epigenetic modification plays a crucial role in triggering the susceptibility of the host towards the pathogen and activating the host's immune system against the invading pathogen. It alters the gene expression modifying the genetic material of the host's cell. Epigenetic modification such as histone acetylation, alteration in non-coding RNA, DNA methylation and alteration in miRNA has been studied for their influence on the pathophysiology of tuberculosis to control the spread of infection. Despite several studies being conducted, many gaps still exist. Herein, we discuss the immunopathophysiological mechanism of tuberculosis, the essentials of epigenetics and the recent encroachment of epigenetics in the field of tuberculosis and its influence on the outcome and pathophysiology of the infection.

Keywords: DNA methylation; Mycobacterium tuberculosis; epigenetics; histone modification; miRNAs.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Consequences of Mycobacterium tuberculosis induced methylation, acetylation and other histone modifications in the host’s immunity. Abbreviations: Ac: acetylation, Me: methylation, IL-1β: interleukin 1-beta, PD1: programmed cell death-1, CTLA4: cytotoxic T-lymphocyte–associated antigen 4, IFN-γ: interferon gamma, TIM3: T-cell immunoglobulin and mucin domain 3, TNF: tumor necrosis factor.
Figure 2
Figure 2
Mechanism of induction of changes due to Mtb infection-induced modifications in the miRNA. Abbreviations: miRNA: micro-RNAs, RISC: RNA-induced silencing complex, Mtb: mycobacteriaum TB, TLR: toll-like receptors, NF-ΚB: nuclear factor kappa B, IFN-γ: interferon gamma, IL: interleukin, CD1c: cluster of differentiation, DC: dendritic cells, TNF: tumor necrosis factor.
Figure 3
Figure 3
Induction of DNA-methylation by Mtb and its subsequent effect on the host immunity. Abbreviations: TF: Transcription factor, DNA: Deoxy ribonucleic acid, Me: Methylation, IL: Interleukin, RAS: Rat sarcoma virus, HIF: Hypoxia inducible factor, WNT: Wingless-related integration site, VD: Vitamin D, PPP: Pentose phosphate pathway.

References

    1. Nadjane Batista Lacerda S., de Abreu Temoteo R.C., Ribeiro Monteiro de Figueiredo T.M., Darliane Tavares de Luna F., Alves Nunes de Sousa M., de Abreu L.L., Luiz Affonso Fonseca F. Individual and social vulnerabilities upon acquiring tuberculosis: A literature systematic review. Int. Arch. Med. 2014;7:35. doi: 10.1186/1755-7682-7-35. - DOI - PMC - PubMed
    1. WHO Report on Infectour Diseas. 20 August 1999. [(accessed on 10 October 2022)]. Available online: http://www.who.int/infectious-disease-report/
    1. WHO . Global Tuberculosis Report 2013. World Health Organization; Geneva, Switzerland: 2013.
    1. Chakraborty A.K. Epidemiology of tuberculosis: Current status in India. Indian J. Med. Res. 2004;120:248–276. - PubMed
    1. Deutsch-Feldman M., Pratt R.H., Price S.F., Tsang C.A., Self J.L. Tuberculosis—United States, 2020. Morb. Mortal. Wkly. Rep. 2021;70:409. doi: 10.15585/mmwr.mm7012a1. - DOI - PMC - PubMed

LinkOut - more resources